159 related articles for article (PubMed ID: 7508864)
1. Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils.
Marone G; Stellato C; Renda A; Genovese A
Eur J Clin Pharmacol; 1993; 45 Suppl 1():S17-20; discussion S43-4. PubMed ID: 7508864
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory Effect of Deflazacort.
Stellato C; Casolaro V; Renda A; Genovese A; Marone G
Int Arch Allergy Immunol; 1992; 99(2-4):340-342. PubMed ID: 34167210
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
6. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
7. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
[TBL] [Abstract][Full Text] [Related]
8. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils.
Plath KE; Grabbe J; Gibbs BF
Clin Exp Allergy; 2003 Mar; 33(3):342-50. PubMed ID: 12614449
[TBL] [Abstract][Full Text] [Related]
11. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
de Paulis A; Ciccarelli A; Marinò I; de Crescenzo G; Marinò D; Marone G
Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pranlukast on histamine release and leukotriene c4 (ltc4) generation from human peripheral basophils].
Ito R; Miura K; Odajima Y; Shimamura T
Arerugi; 2004 Jan; 53(1):19-23. PubMed ID: 14762327
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
Casolaro V; Spadaro G; Patella V; Marone G
J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human basophil leukotriene release by antiinflammatory steroids.
Schleimer RP; Davidson DA; Peters SP; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):241-3. PubMed ID: 3874167
[TBL] [Abstract][Full Text] [Related]
16. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
17. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
[TBL] [Abstract][Full Text] [Related]
18. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous initiation of degranulation and inhibition of leukotriene release by soman in human basophils.
Meier HL; Warner J; MacGlashan DW
Int J Immunopharmacol; 1995 Apr; 17(4):283-9. PubMed ID: 7545649
[TBL] [Abstract][Full Text] [Related]
20. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
